Evidence map›Paper›PMID 29921663›Full record

ArticlemBio2018

Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis.

Noortje de Haan, Navin P Boeddha, Ebru Ekinci, Karli R Reiding, Marieke Emonts, Jan A Hazelzet, Manfred Wuhrer, Gertjan J Driessen

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Immunoglobulin GFrontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Total serumiScience · 2023
    Article
  14. Review
  15. Article
  16. High-Throughput Glycomic Methods.Chemical reviews · 2022
    Review
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Noortje de HaanCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands n.de_haan@lumc.nl.
Navin P BoeddhaIntensive Care and Department of Pediatric Surgery, Erasmus MC, Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Ebru EkinciDivision of Pediatric Infectious Diseases & Immunology, Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Karli R ReidingCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Marieke EmontsInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Jan A HazelzetDepartment of Public Health, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Manfred WuhrerCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Gertjan J DriessenDivision of Pediatric Infectious Diseases & Immunology, Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Erasmus MC - Sophia Children’s Hospital · NLLeiden University Medical Center · NLErasmus MC · NLHaga Hospital · NLNetherlands Metabolomics Centre · NLNewcastle upon Tyne Hospitals NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric meningococcal sepsis often results in morbidity and/or death, especially in young children. Our understanding of the reasons why young children are more susceptible to both the meningococcal infection itself and a more fulminant course of the disease is limited. Immunoglobulin G (IgG) is involved in the adaptive immune response against meningococcal infections, and its effector functions are highly influenced by the glycan structure attached to the fragment crystallizable (Fc) region. It was hypothesized that IgG Fc glycosylation might be related to the susceptibility and severity of meningococcal sepsis. Because of this, the differences in IgG Fc glycosylation between 60 pediatric meningococcal sepsis patients admitted to the pediatric intensive care unit and 46 age-matched healthy controls were investigated, employing liquid chromatography with mass spectrometric detection of tryptic IgG glycopeptides. In addition, Fc glycosylation profiles were compared between patients with a severe outcome (death or the need for amputation) and a nonsevere outcome. Meningococcal sepsis patients under the age of 4 years showed lower IgG1 fucosylation and higher IgG1 bisection than age-matched healthy controls. This might be a direct effect of the disease; however, it can also be a reflection of previous immunologic challenges and/or a higher susceptibility of these children to develop meningococcal sepsis. Within the young patient group, levels of IgG1 hybrid-type glycans and IgG2/3 sialylation per galactose were associated with illness severity and severe outcome. Future studies in larger groups should explore whether IgG Fc glycosylation could be a reliable predictor for meningococcal sepsis outcome.

Indexed as

ChildChild, PreschoolFemaleGlycoproteinsGlycosylationHumansImmunoglobulin Fc FragmentsImmunoglobulin GInfantInflammation MediatorsMaleMeningococcal InfectionsNetherlandsRetrospective StudiesSeverity of Illness IndexGlycoproteinsglycosylated IgGImmunoglobulin Fc FragmentsImmunoglobulin GInflammation Mediatorschildrencritical careFc glycosylationimmunoglobulin Gmeningococcal sepsisN-glycanoutcome

Identifiers

PMID29921663
PMCPMC6016251
OpenAlexW2809035137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.